Гинекология (Nov 2022)

Uterine leiomyosarcoma and disseminated peritoneal leiomyomatosis in the surgical treatment of uterine myoma: a retrospective analysis

  • Alexander A. Seregin,
  • Yana A. Kosova,
  • Polina A. Seregina,
  • Yulia N. Ponomareva,
  • Anastasiia B. Nadezhdenskaia,
  • Eleonora V. Kirilova,
  • Aleksandra V. Asaturova,
  • Anna V. Tregubova,
  • Alina S. Magnaeva,
  • Maria P. Ishchuk,
  • Dmitry L. Ovodenko

DOI
https://doi.org/10.26442/20795696.2022.5.201860
Journal volume & issue
Vol. 24, no. 5
pp. 386 – 392

Abstract

Read online

Aim. To analyze the incidence and types of adverse outcomes and complications of laparoscopic myomectomies. Materials and methods. This work is a retrospective study based on data from the Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology. We analyzed 711 case histories of patients diagnosed with uterine myoma who received surgical treatment in the Department of Innovative Oncology and Gynecology from 2015 to 2019. The frequency of malignant neoplasms, verified by pathomorphological examination, and the characteristics of surgical interventions performed in these patients were comparatively evaluated. Results. Surgical interventions for uterine myoma are leading in gynecology due to the high prevalence of such disorders. Conservative myomectomy remains the "gold standard" in organ-sparing surgery. However, during surgeries for suspected benign neoplasms, there is a risk of morcellation of the malignant tumor, significantly worsening patient survival outcomes. In our study, the incidence of uterine leiomyosarcoma in suspected benign neoplasms was 0.98%. The probability of parasitic myomas or disseminated perineal leiomyomatosis after myomatous nodule morcellation is 0.19%. Conclusion. No reliable information about the malignant potential of the tumor and its proliferative activity can be obtained until a definitive pathomorphological examination. The above considerations warrant the routine use of prophylactic measures to prevent tumor cell dissemination.

Keywords